|
C15ORF38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.823200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.499800E-03 |
| Normal-vs-Stage2 |
6.682100E-02 |
| Normal-vs-Stage3 |
4.693600E-02 |
| Normal-vs-Stage4 |
3.424900E-03 |
| Stage1-vs-Stage2 |
8.510200E-01 |
| Stage1-vs-Stage3 |
8.677000E-01 |
| Stage1-vs-Stage4 |
2.167600E-01 |
| Stage2-vs-Stage3 |
7.782200E-01 |
| Stage2-vs-Stage4 |
4.439400E-01 |
| Stage3-vs-Stage4 |
2.060400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.490130E-02 |
| Normal-vs-AfricanAmerican |
8.878600E-01 |
| Normal-vs-Asian |
5.503700E-02 |
| Caucasian-vs-AfricanAmerican |
2.133800E-01 |
| Caucasian-vs-Asian |
9.168800E-01 |
| AfricanAmerican-vs-Asian |
2.434800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.641500E-04 |
| Normal-vs-Female |
1.736240E-02 |
| Male-vs-Female |
5.064300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.296200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.797500E-03 |
| Normal-vs-Age(61-80Yrs) |
6.461000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.100400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.569400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.404200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.118000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.487600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.495200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.934600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.208600E-01 |
| Classical-VS-Follicular |
4.86779999975262E-07 |
| Classical-VS-Other |
9.616300E-03 |
| Classical-VS-Normal |
1.539790E-01 |
| Tall-VS-Follicular |
1.338330E-02 |
| Tall-VS-Other |
1.466400E-02 |
| Tall-VS-Normal |
6.657900E-02 |
| Follicular-VS-Other |
2.642800E-01 |
| Follicular-VS-Normal |
2.95440000019909E-07 |
| Other-VS-Normal |
4.249700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.618700E-03 |
| Normal-vs-N1 |
1.218340E-02 |
| N0-vs-N1 |
6.800200E-01 |
|
|
